Why the study?
Testing the relevance of in vitro viral mechanistic studies often takes a very long time, prompting the need for in vivo imaging approaches.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Imaging advances enable in vivo viral pathogenesis studies; leaves open clinical translation from experimental models.
Viruses are causative agents for many diseases and infect all living organisms on the planet. Development of effective therapies has relied on our ability to isolate and culture viruses in vitro, allowing mechanistic studies and strategic interventions. While this reductionist approach is necessary, testing the relevance of in vitro findings often takes a very long time. New developments in imaging technologies are transforming our experimental approach where viral pathogenesis can be studied in vivo at multiple spatial and temporal resolutions. Here, we outline a vision of a top-down approach using noninvasive whole-body imaging as a guide for in-depth characterization of key tissues, physiologically relevant cell types, and pathways of spread to elucidate mechanisms of virus spread and pathogenesis. Tool development toward imaging of infectious diseases is expected to transform clinical diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Uchil et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: